nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Instillation site pain—Furosemide—dilated cardiomyopathy	0.0371	0.0371	CcSEcCtD
Meropenem—Application site pain—Furosemide—dilated cardiomyopathy	0.0275	0.0275	CcSEcCtD
Meropenem—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.019	0.019	CcSEcCtD
Meropenem—Cholestasis—Furosemide—dilated cardiomyopathy	0.0159	0.0159	CcSEcCtD
Meropenem—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.0149	0.0149	CcSEcCtD
Meropenem—Injection site pain—Furosemide—dilated cardiomyopathy	0.0148	0.0148	CcSEcCtD
Meropenem—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0146	0.0146	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0145	0.0145	CcSEcCtD
Meropenem—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0138	0.0138	CcSEcCtD
Meropenem—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0138	0.0138	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0123	0.0123	CcSEcCtD
Meropenem—Renal failure—Spironolactone—dilated cardiomyopathy	0.0122	0.0122	CcSEcCtD
Meropenem—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.0118	0.0118	CcSEcCtD
Meropenem—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0116	0.0116	CcSEcCtD
Meropenem—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0105	0.0105	CcSEcCtD
Meropenem—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0103	0.0103	CcSEcCtD
Meropenem—Accidental injury—Lisinopril—dilated cardiomyopathy	0.0102	0.0102	CcSEcCtD
Meropenem—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.0101	0.0101	CcSEcCtD
Meropenem—Cough increased—Lisinopril—dilated cardiomyopathy	0.0099	0.0099	CcSEcCtD
Meropenem—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00972	0.00972	CcSEcCtD
Meropenem—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00965	0.00965	CcSEcCtD
Meropenem—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00952	0.00952	CcSEcCtD
Meropenem—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00907	0.00907	CcSEcCtD
Meropenem—Malaise—Spironolactone—dilated cardiomyopathy	0.00876	0.00876	CcSEcCtD
Meropenem—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00869	0.00869	CcSEcCtD
Meropenem—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00856	0.00856	CcSEcCtD
Meropenem—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00851	0.00851	CcSEcCtD
Meropenem—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00822	0.00822	CcSEcCtD
Meropenem—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00807	0.00807	CcSEcCtD
Meropenem—Confusional state—Spironolactone—dilated cardiomyopathy	0.00799	0.00799	CcSEcCtD
Meropenem—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00798	0.00798	CcSEcCtD
Meropenem—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00792	0.00792	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.0079	0.0079	CcSEcCtD
Meropenem—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00776	0.00776	CcSEcCtD
Meropenem—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00763	0.00763	CcSEcCtD
Meropenem—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00751	0.00751	CcSEcCtD
Meropenem—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00732	0.00732	CcSEcCtD
Meropenem—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00729	0.00729	CcSEcCtD
Meropenem—Injury—Lisinopril—dilated cardiomyopathy	0.00716	0.00716	CcSEcCtD
Meropenem—Somnolence—Spironolactone—dilated cardiomyopathy	0.00704	0.00704	CcSEcCtD
Meropenem—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00684	0.00684	CcSEcCtD
Meropenem—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00674	0.00674	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0067	0.0067	CcSEcCtD
Meropenem—Renal failure—Furosemide—dilated cardiomyopathy	0.00664	0.00664	CcSEcCtD
Meropenem—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00653	0.00653	CcSEcCtD
Meropenem—Sweating—Furosemide—dilated cardiomyopathy	0.00648	0.00648	CcSEcCtD
Meropenem—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00639	0.00639	CcSEcCtD
Meropenem—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00631	0.00631	CcSEcCtD
Meropenem—Urticaria—Spironolactone—dilated cardiomyopathy	0.00629	0.00629	CcSEcCtD
Meropenem—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00626	0.00626	CcSEcCtD
Meropenem—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00626	0.00626	CcSEcCtD
Meropenem—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00617	0.00617	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00593	0.00593	CcSEcCtD
Meropenem—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00584	0.00584	CcSEcCtD
Meropenem—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00574	0.00574	CcSEcCtD
Meropenem—Asthma—Lisinopril—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Meropenem—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00563	0.00563	CcSEcCtD
Meropenem—Pruritus—Spironolactone—dilated cardiomyopathy	0.00561	0.00561	CcSEcCtD
Meropenem—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00548	0.00548	CcSEcCtD
Meropenem—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00542	0.00542	CcSEcCtD
Meropenem—Dysuria—Lisinopril—dilated cardiomyopathy	0.00532	0.00532	CcSEcCtD
Meropenem—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00532	0.00532	CcSEcCtD
Meropenem—Erythema—Furosemide—dilated cardiomyopathy	0.00528	0.00528	CcSEcCtD
Meropenem—Dizziness—Spironolactone—dilated cardiomyopathy	0.00524	0.00524	CcSEcCtD
Meropenem—Flatulence—Furosemide—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Meropenem—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00517	0.00517	CcSEcCtD
Meropenem—Pneumonia—Lisinopril—dilated cardiomyopathy	0.0051	0.0051	CcSEcCtD
Meropenem—Vomiting—Spironolactone—dilated cardiomyopathy	0.00504	0.00504	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00503	0.00503	CcSEcCtD
Meropenem—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.005	0.005	CcSEcCtD
Meropenem—Rash—Spironolactone—dilated cardiomyopathy	0.005	0.005	CcSEcCtD
Meropenem—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00499	0.00499	CcSEcCtD
Meropenem—Renal failure—Lisinopril—dilated cardiomyopathy	0.00499	0.00499	CcSEcCtD
Meropenem—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00497	0.00497	CcSEcCtD
Meropenem—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00497	0.00497	CcSEcCtD
Meropenem—Headache—Spironolactone—dilated cardiomyopathy	0.00496	0.00496	CcSEcCtD
Meropenem—Jaundice—Lisinopril—dilated cardiomyopathy	0.00494	0.00494	CcSEcCtD
Meropenem—Anaemia—Furosemide—dilated cardiomyopathy	0.00488	0.00488	CcSEcCtD
Meropenem—Sweating—Lisinopril—dilated cardiomyopathy	0.00486	0.00486	CcSEcCtD
Meropenem—Agitation—Furosemide—dilated cardiomyopathy	0.00485	0.00485	CcSEcCtD
Meropenem—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.0048	0.0048	CcSEcCtD
Meropenem—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00478	0.00478	CcSEcCtD
Meropenem—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Meropenem—Leukopenia—Furosemide—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Meropenem—Nausea—Spironolactone—dilated cardiomyopathy	0.00471	0.00471	CcSEcCtD
Meropenem—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00463	0.00463	CcSEcCtD
Meropenem—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00455	0.00455	CcSEcCtD
Meropenem—Hallucination—Lisinopril—dilated cardiomyopathy	0.00453	0.00453	CcSEcCtD
Meropenem—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00452	0.00452	CcSEcCtD
Meropenem—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00449	0.00449	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00447	0.00447	CcSEcCtD
Meropenem—Confusional state—Furosemide—dilated cardiomyopathy	0.00435	0.00435	CcSEcCtD
Meropenem—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00431	0.00431	CcSEcCtD
Meropenem—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.0043	0.0043	CcSEcCtD
Meropenem—Shock—Furosemide—dilated cardiomyopathy	0.00424	0.00424	CcSEcCtD
Meropenem—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00423	0.00423	CcSEcCtD
Meropenem—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Meropenem—Skin disorder—Furosemide—dilated cardiomyopathy	0.00419	0.00419	CcSEcCtD
Meropenem—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00417	0.00417	CcSEcCtD
Meropenem—Anorexia—Furosemide—dilated cardiomyopathy	0.00411	0.00411	CcSEcCtD
Meropenem—Chills—Lisinopril—dilated cardiomyopathy	0.00409	0.00409	CcSEcCtD
Meropenem—Hypotension—Furosemide—dilated cardiomyopathy	0.00403	0.00403	CcSEcCtD
Meropenem—Erythema—Lisinopril—dilated cardiomyopathy	0.00396	0.00396	CcSEcCtD
Meropenem—Flatulence—Lisinopril—dilated cardiomyopathy	0.00391	0.00391	CcSEcCtD
Meropenem—Tension—Lisinopril—dilated cardiomyopathy	0.00389	0.00389	CcSEcCtD
Meropenem—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00388	0.00388	CcSEcCtD
Meropenem—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Meropenem—Nervousness—Lisinopril—dilated cardiomyopathy	0.00385	0.00385	CcSEcCtD
Meropenem—Back pain—Lisinopril—dilated cardiomyopathy	0.00383	0.00383	CcSEcCtD
Meropenem—Somnolence—Furosemide—dilated cardiomyopathy	0.00383	0.00383	CcSEcCtD
Meropenem—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00375	0.00375	CcSEcCtD
Meropenem—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00372	0.00372	CcSEcCtD
Meropenem—Pain—Furosemide—dilated cardiomyopathy	0.00369	0.00369	CcSEcCtD
Meropenem—Constipation—Furosemide—dilated cardiomyopathy	0.00369	0.00369	CcSEcCtD
Meropenem—Anaemia—Lisinopril—dilated cardiomyopathy	0.00366	0.00366	CcSEcCtD
Meropenem—Angioedema—Lisinopril—dilated cardiomyopathy	0.00362	0.00362	CcSEcCtD
Meropenem—Malaise—Lisinopril—dilated cardiomyopathy	0.00357	0.00357	CcSEcCtD
Meropenem—Syncope—Lisinopril—dilated cardiomyopathy	0.00355	0.00355	CcSEcCtD
Meropenem—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00355	0.00355	CcSEcCtD
Meropenem—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00355	0.00355	CcSEcCtD
Meropenem—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00353	0.00353	CcSEcCtD
Meropenem—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00348	0.00348	CcSEcCtD
Meropenem—Cough—Lisinopril—dilated cardiomyopathy	0.00346	0.00346	CcSEcCtD
Meropenem—Urticaria—Furosemide—dilated cardiomyopathy	0.00342	0.00342	CcSEcCtD
Meropenem—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00341	0.00341	CcSEcCtD
Meropenem—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00341	0.00341	CcSEcCtD
Meropenem—Chest pain—Lisinopril—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Meropenem—Anxiety—Lisinopril—dilated cardiomyopathy	0.00336	0.00336	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00335	0.00335	CcSEcCtD
Meropenem—Confusional state—Lisinopril—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Meropenem—Oedema—Lisinopril—dilated cardiomyopathy	0.00323	0.00323	CcSEcCtD
Meropenem—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00323	0.00323	CcSEcCtD
Meropenem—Infection—Lisinopril—dilated cardiomyopathy	0.00321	0.00321	CcSEcCtD
Meropenem—Shock—Lisinopril—dilated cardiomyopathy	0.00318	0.00318	CcSEcCtD
Meropenem—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00318	0.00318	CcSEcCtD
Meropenem—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00317	0.00317	CcSEcCtD
Meropenem—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00316	0.00316	CcSEcCtD
Meropenem—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00314	0.00314	CcSEcCtD
Meropenem—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Meropenem—Asthenia—Furosemide—dilated cardiomyopathy	0.00309	0.00309	CcSEcCtD
Meropenem—Anorexia—Lisinopril—dilated cardiomyopathy	0.00308	0.00308	CcSEcCtD
Meropenem—Pruritus—Furosemide—dilated cardiomyopathy	0.00305	0.00305	CcSEcCtD
Meropenem—Hypotension—Lisinopril—dilated cardiomyopathy	0.00302	0.00302	CcSEcCtD
Meropenem—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Meropenem—Insomnia—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Meropenem—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.0029	0.0029	CcSEcCtD
Meropenem—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Meropenem—Somnolence—Lisinopril—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Meropenem—Dizziness—Furosemide—dilated cardiomyopathy	0.00285	0.00285	CcSEcCtD
Meropenem—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00285	0.00285	CcSEcCtD
Meropenem—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00281	0.00281	CcSEcCtD
Meropenem—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Meropenem—Constipation—Lisinopril—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Meropenem—Pain—Lisinopril—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Meropenem—Vomiting—Furosemide—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Meropenem—Rash—Furosemide—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Meropenem—Dermatitis—Furosemide—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Meropenem—Headache—Furosemide—dilated cardiomyopathy	0.0027	0.0027	CcSEcCtD
Meropenem—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00267	0.00267	CcSEcCtD
Meropenem—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00265	0.00265	CcSEcCtD
Meropenem—Urticaria—Lisinopril—dilated cardiomyopathy	0.00257	0.00257	CcSEcCtD
Meropenem—Nausea—Furosemide—dilated cardiomyopathy	0.00256	0.00256	CcSEcCtD
Meropenem—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00256	0.00256	CcSEcCtD
Meropenem—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00256	0.00256	CcSEcCtD
Meropenem—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Meropenem—Asthenia—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Meropenem—Pruritus—Lisinopril—dilated cardiomyopathy	0.00229	0.00229	CcSEcCtD
Meropenem—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00221	0.00221	CcSEcCtD
Meropenem—Dizziness—Lisinopril—dilated cardiomyopathy	0.00214	0.00214	CcSEcCtD
Meropenem—Vomiting—Lisinopril—dilated cardiomyopathy	0.00206	0.00206	CcSEcCtD
Meropenem—Rash—Lisinopril—dilated cardiomyopathy	0.00204	0.00204	CcSEcCtD
Meropenem—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00204	0.00204	CcSEcCtD
Meropenem—Headache—Lisinopril—dilated cardiomyopathy	0.00203	0.00203	CcSEcCtD
Meropenem—Nausea—Lisinopril—dilated cardiomyopathy	0.00192	0.00192	CcSEcCtD
